-
Lamotrigine: From BBB Assays to Translation
2026-08-26
A translational framework for positioning Lamotrigine in exposure-aware CNS research, combining sodium channel and serotonin biology with BBB permeability, lysosomal trapping, and cardiac sodium current considerations.
-
ERAD Chimeras for Targeted Membrane Protein Degradation
2026-08-26
Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule targeted protein degradation platform that recruits the ER E3 ligase SYVN1 to eliminate transmembrane proteins. The study demonstrates potent PD-L1 degradation, improved tumor suppression relative to a clinically used antibody in vivo, and broader utility through desonide-enabled degradation of mutant huntingtin.
-
Bismuth Subsalicylate in GI Cell Assays
2026-08-25
Bismuth Subsalicylate can anchor gastrointestinal disorder research when prostaglandin pathway modulation is paired with a direct membrane-injury readout. This workflow uses recombinant annexin V to separate early phosphatidylserine exposure from later loss of membrane integrity while addressing the compound’s water insolubility and suspension-driven variability.
-
SB-505124 Hydrochloride in Causal Biology
2026-08-25
SB-505124 hydrochloride provides a selective way to test whether ALK4/5/7 signaling contributes to fibrosis, mechanotransduction, or cancer-cell phenotypes. This article develops a causal assay framework that connects Smad2/3 signaling with the MRTFA–KCNMB1 stiffness axis without conflating correlation with mechanism.
-
PCMT1 and Ovarian Cancer Metastasis: CRISPR Study
2026-08-24
Zhang et al. used a genome-wide CRISPR/Cas9 knockout screen to identify PCMT1 as a driver of anoikis resistance and ovarian cancer dissemination. The study connects extracellular PCMT1 to LAMB3–integrin–FAK–Src signaling, providing a mechanistic explanation for enhanced adhesion, spheroid growth, invasion, ascites formation, and distant metastasis.
-
EdU Imaging Kits: Reading Drug Response in RCC
2026-08-24
EdU Imaging Kits connect S-phase DNA synthesis measurement with mechanistic drug-response studies in renal cell carcinoma. This guide shows how the K2240 assay can clarify whether syringin and sunitinib suppress proliferation, while avoiding overinterpretation of a single endpoint.
-
I-BET-762 Workflows for BET Inhibition Research
2026-08-23
I-BET-762 is a selective BET inhibitor for connecting transcriptional control with inflammatory signaling and ferroptosis-focused cancer assays. This practical guide covers solvent handling, combination workflows, mechanistic readouts, and troubleshooting for more reproducible preclinical studies.
-
KU-60019: ATM Kinase Inhibitor Workflows
2026-08-22
KU-60019 provides a selective way to interrogate ATM-dependent DNA damage signaling, glioma invasion, and radiation response in matched cell models. This workflow-focused guide connects dose planning, pathway readouts, migration assays, and troubleshooting with the mechanistic lessons of a recent DNA methylation study.
-
OSMI-1: A Practical O-GlcNAc Transferase Inhibitor Guide
2026-08-22
OSMI-1 provides a cell-permeable loss-of-function approach for connecting OGT activity with protein modification, iron handling, and ferroptosis. This workflow-focused guide explains how to dose, verify target engagement, separate pathway effects from cytotoxicity, and translate findings from general cell assays into trophoblast-focused experiments.
-
REV1–DHX36 Coordination of G-Quadruplex Replication
2026-08-21
Ketkar and colleagues identify a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The work provides a mechanistic framework for understanding how G4 stabilization reshapes replication tolerance and amplifies DNA damage response signaling.
-
Cytosolic DNA and TDP-43 Homeostasis in ALS
2026-08-20
Yang and colleagues show that cytosolic DNA can reorganize TDP-43 into reversible condensates and, when persistent, drive nuclear depletion, KPNB1 sequestration, and increased production of a short TDP-43 isoform. The study connects DNA accumulation, DNA damage, and nuclear-envelope compromise with TDP-43 proteinopathy while providing experimentally testable models for neurodegeneration research.
-
CD28–ARS2 Control of CD8+ T Cell Metabolism
2026-08-20
Holling and colleagues identify a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM in activated CD8+ T cells, favoring PKM2 and supporting glucose-use flexibility, interferon-γ production, and antitumor activity. The study connects costimulatory signaling to post-transcriptional metabolic control and provides a framework for separating splicing-dependent effects from canonical PI3K-mediated glucose regulation.
-
Meropenem Trihydrate: Reading Resistance by Metabolomics
2026-08-19
Meropenem trihydrate is more than a broad-spectrum carbapenem antibiotic: it can anchor controlled studies of bacterial physiology, resistance phenotypes, and infection-model confounding. This article translates recent LC-MS/MS metabolomics findings into practical assay decisions for antibiotic resistance studies and bacterial infection treatment research.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-08-19
2-Hydroxypropyl-β-cyclodextrin (SKU B6413) is a water-soluble cyclic oligosaccharide used to improve the handling of poorly water-soluble, hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. It is appropriate for pharmaceutical solubility improvement, drug formulation excipient workflows, and related biochemical formulation studies, but the supplied dossier does not support therapeutic claims or unrelated applications.
-
BCL-XL inhibitor A-1155463: Applied Workflows
2026-08-18
Build mechanism-led cancer assays with A-1155463, from BCL-XL dependency mapping and apoptosis profiling to exploratory tumor studies. Its nanomolar affinity, DMSO compatibility, and reported platelet recovery profile make it useful for separating pathway activity from formulation and model-specific artifacts.